Last updated on November 2018

A Study of Baricitinib (LY3009104) in Adults With Moderate to Severe Atopic Dermatitis


Brief description of study

The purpose of this study is to evaluate the efficacy and safety of baricitinib as monotherapy in participants with moderate to severe atopic dermatitis.

Clinical Study Identifier: NCT03334396

Contact Investigators or Research Sites near you

Start Over

There may be multiple sites ...

Sumire Dermatology Clinic
Edogawa-ku, Japan
1.89miles
  Connect »

There may be multiple sites ...

Kawashima Dermatology Clinic
Ichikawa-shi, Japan
3.27miles
  Connect »

There may be multiple sites ...

Nihonbashi Sakura Clinic
Chuo-ku, Japan
5.82miles
  Connect »

There may be multiple sites ...

Iidabashi Clinic
Chiyoda-ku, Japan
6.25miles
  Connect »